Odanacatib
- Generic Name
- Odanacatib
- Drug Type
- Small Molecule
- Chemical Formula
- C25H27F4N3O3S
- CAS Number
- 603139-19-1
- Unique Ingredient Identifier
- N673F6W2VH
Overview
Odanacatib is an inhibiter of cathepsin K which was originally developed be Merck & Co as a new treatment for osteoporosis . The drug made it to phase III trials before abandoned due to increased stroke.
Background
Odanacatib is an inhibiter of cathepsin K which was originally developed be Merck & Co as a new treatment for osteoporosis . The drug made it to phase III trials before abandoned due to increased stroke.
Indication
Investigated for use/treatment in osteoporosis .
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath